Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Genetics

Genetics: Discovering the Unknown in Breast Cancer

Genetics: Discovering the Unknown in Breast Cancer

BY BRIELLE BENYON

All Patients With GI Cancers Should Undergo NGS

All Patients With GI Cancers Should Undergo NGS

BY TANIOS S. BEKAII-SAAB, MD

Biomarkers Predict Osteosarcoma Treatment Response

Biomarkers Predict Osteosarcoma Treatment Response

BY ELLIE LEICK

Expert Talks Liquid Biopsies, Molecular Testing in Lung Cancer

Expert Talks Liquid Biopsies, Molecular Testing in Lung Cancer

BY ELLIE LEICK

Genetic Testing and Inherited Increased Risk of Cancer

Genetic Testing and Inherited Increased Risk of Cancer

BY CANCERCARE

New Agents Show Promise in Treating Patients with IDH1-Mutant Low-Grade Glioma

New Agents Show Promise in Treating Patients with IDH1-Mutant Low-Grade Glioma

BY GINA COLUMBUS

Next-Generation Sequencing Sets Sights On Rare Mutations in Lung Cancer

Next-Generation Sequencing Sets Sights On Rare Mutations in Lung Cancer

BY ELLIE LEICK

Searching for Prognostic Markers in Patients with Osteosarcoma

Searching for Prognostic Markers in Patients with Osteosarcoma

BY ELHAM NASRI, MD

New Pathway Emerges as A Favorable Target in CRC

New Pathway Emerges as A Favorable Target in CRC

BY CAROLINE SEYMOUR

Additional Therapeutic Options for Patients With ALK+ and ROS1+ Lung Cancer Emerge

Additional Therapeutic Options for Patients With ALK+ and ROS1+ Lung Cancer Emerge

BY JESSICA HERGERT

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.